Figure 3

Log hazard ratio for mortality among all HIV-infected tuberculosis patients (n = 174) and patients who had bacteriologic-confirmed tuberculosis (n = 127) and initiated ART during anti-tuberculosis treatment. TB, tuberculosis, HIV, human immunodeficiency virus; ART, anti-retroviral therapy; HR, hazard ratio; CI, confidence interval; only those who received a TB regimen of known efficacy and started ART at the beginning or during TB treatment were included; the analyses were adjusted for TB disease severity and CD4. *Among all TB patients. ^†Among bacteriologic-confirmed TB patients.